Key PointsBristol-Myers Squibb offers a deep focus on oncology and hematology with a favorable valuation.

Bristol-Myers Squibb vs. Johnson & Johnson: Which Healthcare Stock Is a Better Buy in 2026?

Key PointsOperational sales grew 6% in the third quarter of 2026.

Johnson & Johnson: 3 Key Takeaways for Long-Term Investors

Key PointsThe S&P 500 Growth index exclusively holds 151 of the best-performing growth stocks from the regular S&P 500.

This Unstoppable Vanguard ETF Could Turn $500 Per Month Into $1 Million Over the Long Term

Key PointsU.S. megacap growth stocks such as Nvidia, Apple, Alphabet, Microsoft, and Amazon have altered the composition of major indexes like the S&P 500.

Meet the Low-Cost Vanguard ETF With Taiwan Semiconductor, Samsung Electronics, SK Hynix, and ASML as Its 4 Largest Holdings

@media (max-width: 768px) {
                .image-container {
                    width: 100% !important;
                    float: none !important;
                    margin: 0 0 1rem 0 !important;
                }
            }
        



Image source: The Mo

J&J (JNJ) Q3 2026 Earnings Call Transcript

The S&P 500 Index ($SPX ) (SPY ) closed down by -0.02% on Tuesday, the Dow Jones Industrial Average ($DOWI ) (DIA ) closed down by -0.35%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -0.31%.  December E-mini S&P futures (ESZ26 ) fell -0.02%, and December E-mini...

Stocks Finish Lower Ahead of Wednesday’s CPI Report

Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of a range of products in the healthcare field worldwide. It operates in two segments, Innovative Medicine and MedTech. The Innovative Medicine segment offers products for various therapeutic areas, such as oncology, immunology, neuroscience, pulmonary hypertension, infectious diseases, and cardiovascular and metabolism distributed through retailers, wholesalers, distributors, hospitals, and healthcare professionals for prescription use. The MedTech segment provides a portfolio of products used in the surgery, orthopedic, cardiovascular, and vision fields distributed through wholesalers, hospitals and retailers, and used in the professional fields by physicians, nurses, hospitals, eye care professionals and clinics. This segment also offers products and enabling technologies that support joint reconstruction, trauma, spine, sports related injuries, and others, as well as open, laparoscopic, and robotic surgical procedures; instrumentation, energy devices, stapling systems, wound closure, biosurgery products, and digital and robotic technologies; breast aesthetics and reconstruction; contact lenses under the ACUVUE brand; intraocular lenses for cataract surgery, and other products used in cataract and refractive procedures under the TECNIS brand. The company was founded in 1886 and is based in New Brunswick, New Jersey.

Johnson & Johnson News